secwatch.observer — SEC 8-K summary
======================================

Issuer:     Akebia Therapeutics, Inc. (AKBA)
CIK:        0001517022
Form:       8-K
Filed at:   2023-12-18T23:59:59+00:00
Accession:  0001517022-23-000046
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Akebia extends manufacturing supply agreement with Siegfried through 2026
-------------------------------------------------------------------------

- Exercised option to extend Master Manufacturing Services and Supply Agreement with Siegfried Evionnaz SA.
- Term extended from December 31, 2024 to December 31, 2026.
- Extension notice provided on December 14, 2023; all other terms unchanged.
- Supply continuity secured for active pharmaceutical ingredient manufacturing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517022/000151702223000046/0001517022-23-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517022/000151702223000046/akba-20231214.htm
  HTML page:      https://secwatch.observer/filing/0001517022-23-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer